Login / Signup

Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.

Miho YoshidaNaoe JimboRyuko TsukamotoTomoo ItohKunimitsu KawaharaSuguru MitsuiYugo TanakaYoshimasa Maniwa
Published in: Diagnostic pathology (2023)
Our case suggests that cell-in-cell engulfment can be conspicuous in early-stage mesothelioma with inconspicuous nuclear atypia and few multinucleated cells. In addition, the presence of MTAP loss and CDKN2A homozygous deletion are suspected to be involved in early formation to invasive lesions and/or sarcomatoid morphology. We believe that it is important to consider genetic abnormalities when deciding on individual patient management. Furthermore, cases of mesothelioma, even those of an in situ lesion, with MTAP loss and/or CDKN2A deletion should be carefully followed up or subjected to early treatment.
Keyphrases
  • early stage
  • single cell
  • case report
  • cell therapy
  • sentinel lymph node
  • gene expression
  • stem cells
  • dna methylation
  • cell cycle arrest
  • genome wide
  • mesenchymal stem cells
  • replacement therapy